The University of Tennessee Health Science Center has been awarded $3.2 million from the National Institute of Allergy and Infectious Diseases (NIAID) to upgrade the equipment and infrastructure in the UTHSC Regional Biocontainment Laboratory (RBL) on the Memphis campus to enhance the university’s research of infectious diseases, including COVID-19.
The University of Tennessee Health Science Center has landed $3.2 million in federal money to upgrade a laboratory used for research on infectious diseases. In a news release, the Memphis campus says the the National Institute of Allergy and Infectious Diseases awarded the money for equipment and infrastructure improvements at the Regional Biocontainment Laboratory.
There are promising new laboratory results in an award-winning effort to find naturally occurring compounds that are therapeutic against the COVID-19 virus. So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 that have shown computational efficacy are undergoing first-batch testing at… Read More
